Together, we can drive research forward and transform healthcare
Collaborating with Signature
We are always interested in exploring opportunities to work with medical innovators who share our core values and are dedicated to advancing science and technology. Through strong collaborative partnerships, we can work together to meet research goals, inspire innovation, and create a lasting impact in healthcare technology.
Who we work with and what we do
Medical and Academic Health Research Organizations
Academic institutions and health research organizations are vital to the advancement and implementation of health research innovations. Becoming a Signature Collaboration Partner gives you access to our turnkey CLIA-certified laboratory operations and analytics platform in collaboration with our professionally skilled analytics team. Our collaborative offerings extend beyond the lab, and we are committed to sharing our wealth of knowledge in scientific innovation and business expertise to directly support healthcare initiatives within your organization and create mutually beneficial relationships.
Here's what you gain access to as a Signature Collaboration Partner:
- Direct assistance designing, managing, and establishing goals of research projects
- Collaborate to find creative ways for funding projects
- Strategies to expand relevant data to meet project goals
- Sourcing patients and samples for research projects
- Expanding diagnostic testing services
Pharmaceutical and Life Science Companies
Precision medicine gives us the opportunity to shape the future of individualized care. We are looking for partners in the pharmaceutical industry that are focused on research and innovation to create the most effective treatment for patients. Our research and analytical platform provide insights that can help support therapeutic development.
Here’s what you gain access to as a Signature Collaboration Partner:
- Identification of epigenomic changes that define phenotypes through noninvasive tissue biopsies – identifying the right patient
- Early-stage disease detection through identifying biomarkers across cell types – get a deeper understanding of cells and cellular function impacted by disease
- Population-based analyses to correlate phenotypic markers with treatment options – get the right therapeutic to the right patient
- Measurement of cell type-specific epigenomic signatures in cell-free DNA to determine drug efficacy - monitor disease progression in response to therapeutics
Interested in collaborating?